查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球外科成像市場 - 2023-2030年
市場調查報告書
商品編碼
1290360

全球外科成像市場 - 2023-2030年

Global Surgical Imaging Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球外科成像市場的規模在2022年達到20.473億美元，預計到2030年將見證有利可圖的成長，達到33305億美元。在預測期內（2023-2030），全球外科成像市場預計將呈現6.4%的複合年成長率。

手術成像在腫瘤手術中至關重要，包括腫瘤切除術、活體組織切片程序和淋巴結切除術。腫瘤外科醫生通過使用包括CT、MRI和PET-CT掃描在內的成像方式，幫助腫瘤定位、分期和確定手術切除的精確邊緣，能夠最佳化手術方法，保證腫瘤的完全切除。

市場動態

慢性疾病的負擔日益加重，在預測期內推動了全球外科成像市場的成長。

在工業化國家和發展中國家，慢性非傳染性疾病（NCDs）構成死亡和殘疾的主要原因。全球每10人中就有7人死於四種主要的非傳染性疾病：癌症、心血管疾病、慢性呼吸系統疾病和糖尿病。 80%與非傳染性疾病相關的死亡發生在低收入和中等收入國家。

根據世界衛生組織（WHO）2022年的估計，非傳染性疾病（NCDs）每年造成4100萬人死亡，佔全世界所有死亡人數的74%。全世界每年有1700萬人在70歲之前死於非傳染性疾病；這些過早的死亡有86%發生在低收入和中等收入國家。

技術進步為外科成像市場提供了潛在的成長機會

為了在未來的外科手術中成功互補，人類和醫療技術將需要越來越多的合作。例如，2022年1月，由健康技術組織皇家飛利浦公司開發的圖像引導治療移動C臂系統- Zenition，現在將為醫生提供先進的新的3D圖像引導能力，提高臨床準確性和效率，旨在提高接受血管內治療的病人的效果。

COVID-19影響分析

COVID-19大流行病對外科成像市場產生了重大影響。由於該大流行病對外科專業的實質性和廣泛的影響，全球範圍內的選擇性手術都被推遲了。

根據2022年發表在Jornal of Minimal Access Surgery上的文章，與傳統的開放性手術相比，微創手術（MIS）採用較小的切口，對組織的損傷較小，失血量最小，縮短了病人必須住院的時間，並產生了良好的短期和可比的長期效果。為了對抗這種大流行病，外科醫生可以在MIS領域獲得成功。

俄羅斯-烏克蘭衝突分析

俄烏戰爭對外科影像市場的影響是複雜和多方面的。在衝突期間，醫療資源和優先事項可能轉向緊急和創傷護理，對非緊急程序和外科成像系統等專業設備的關注和投資較少。由於醫療系統優先考慮即時和關鍵的需求，而不是投資於先進的成像技術，因此對外科成像的需求受到影響。

目錄

第一章：方法和範圍

  • 研究方法
  • 報告的研究目標和範圍

第二章：定義和概述

第三章：執行摘要

  • 按產品分類的摘要
  • 按技術分類
  • 按模式分析
  • 按應用分類
  • 按終端用戶分類
  • 按地區分類

第4章：動態變化

  • 影響因素
    • 驅動因素
      • 慢性疾病發病率的增加推動了全球外科成像市場的成長。
    • 限制因素
      • 設備成本高，阻礙了全球外科成像市場的成長。
    • 機會
      • 技術進步
    • 影響分析

第五章：行業分析

  • 波特五力分析
  • 供應鏈分析
  • 未滿足的需求
  • 監管分析

第六章：COVID-19分析

  • 對COVID-19的分析
    • COVID-19之前的情況
    • COVID-19期間的情況
    • COVID-19之後的情況
  • 在COVID-19期間的定價動態
  • 需求-供應譜系
  • 大流行期間與市場有關的政府計劃
  • 製造商的戰略計劃
  • 結語

第7章：俄羅斯-烏克蘭戰爭分析

第八章：人工智慧分析

第九章：按產品分類

  • C-武器
  • O型軍械
  • G-Arms
  • 影像配件
  • 其他產品

第十章：按技術分類

  • 平板檢測器
  • 圖像增強器
  • 其他技術

第11章：按模式分類

  • X-射線
  • 核磁共振成像
  • CT掃描
  • 超音波
  • 其他

第十二章：按應用分類

  • 神經系統成像
  • 骨科和創傷成像
  • 心血管成像
  • 胃腸道成像
  • 普通外科成像
  • 泌尿系統成像
  • 其他

第13章：按終端用戶分類

  • 醫院
  • 非住院外科診所
  • 專科診所
  • 其他

第十四章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第15章：競爭格局

  • 競爭格局
  • 產品標杆
  • 公司佔有率分析
  • 主要發展和戰略

第16章：公司簡介

  • GE Healthcare
    • 公司概述
    • 產品組合和描述
    • 財務概況
    • 主要發展情況
  • Medtronic Plc.
  • Siemens Healthineers AG
  • Thales Group
  • Shimadzu Corporation
  • Hitachi Ltd
  • Koninklijke Philips NV
  • Ziehm Imaging GmbH
  • OrthoScan Inc.
  • Genoray Co. Ltd.

第十七章：附錄

簡介目錄
Product Code: MD1541

Market Overview

The Global Surgical Imaging Market size reached US$ 2,047.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 3,330.5 billion by 2030. The global surgical imaging market is expected to exhibit a CAGR of 6.4% during the forecast period (2023-2030).

Surgical imaging is crucial in oncological surgeries, including tumor resections, biopsy procedures, and lymph node dissections. Oncologic surgeons are able to optimize the surgical approach and guarantee total tumor excision by using imaging modalities including CT, MRI, and PET-CT scans that aid in tumor localization, staging, and determining precise margins for surgical removal.

Market Dynamics

The Growing Burden Of Chronic Diseases Is Boosting The Global Surgical Imaging Market Growth During The Forecast Period.

In both industrialized and developing countries, chronic non-communicable diseases (NCDs) constitute the main cause of death and disability. Seven out of ten fatalities globally are caused by the four primary NCDs: cancer, cardiovascular disease, chronic respiratory illnesses, and diabetes. Eighty percent of NCD-related deaths take place in low- and middle-income nations.

According to a World Health Organisation (WHO) estimate from 2022, noncommunicable diseases (NCDs) account for 41 million annual deaths or 74% of all fatalities worldwide. 17 million people worldwide pass away from an NCD before they turn 70 each year; 86% of these untimely deaths take place in low- and middle-income nations.

Technological Advancements Are Providing The Surgical Imaging Market With Prospective Growth Opportunities

In order to successfully complement each other's work in the future of surgery, humans and healthcare technology will need to work together more and more. For instance, in January 2022, The Image-Guided Therapy Mobile C-arm System - Zenition, developed by Royal Philips, a health technology organization, will now provide physicians with advanced new 3D image guidance capabilities, enhancing clinical accuracy and efficiency and aim to improve the results for patients receiving endovascular treatment.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the surgical imaging market. Elective surgeries have been postponed globally as a result of the pandemic's substantial and wide-ranging impact on surgical specialties.

As per the article published in Jornal of Minimal Access Surgery in 2022, when compared to traditional open surgery, minimally invasive surgery (MIS) employs a smaller incision, causes less damage to tissues, minimizes blood loss, shortens the time patients must stay in the hospital and produces superior short-term and comparable long-term results. In order to combat this pandemic, surgeons could achieve success in the field of MIS.

Russia-Ukraine Conflict Analysis

The impact of the Russia-Ukraine war on the surgical imaging market is complex and multifaceted. During times of conflict, healthcare resources and priorities may shift towards emergency and trauma care, leaving less focus and investment in non-emergency procedures and specialized equipment like surgical imaging systems. The demand for surgical imaging is impacted as healthcare systems prioritize immediate and critical needs over investments in advanced imaging technologies.

Segment Analysis

The global surgical imaging market is segmented based on product, material, distribution channel, end-user, and region.

The Gastrointestinal Imaging Segment Is Expected To Hold A Dominant Position In The Market Over The Forecast Period.

The gastrointestinal imaging segment accounted for the highest market stake accounting for approximately 25.3% of the surgical imaging market in 2022. Surgical imaging plays a significant role in gastrointestinal procedures such as laparoscopic or robotic-assisted surgeries for conditions like colorectal cancer, gallbladder diseases, and bariatric surgery.

Furthermore, in September 2022, the newest surgical visualization platform from Olympus Corporation, a manufacturer of optics and reprography products, VISERA ELITE III, was introduced to meet the needs of healthcare professionals (HCPs) performing endoscopic procedures in a variety of medical specialties. Numerous imaging capabilities provided by VISERA ELITE III, supported by a single system, enable minimally invasive procedures such as laparoscopic colectomy and laparoscopic cholecystectomies.

Geographical Analysis

Increasing Collaborations And Partnerships Among The Key Players, Increasing Chronic Diseases, And Advancement In Surgical Imaging Dominate the North American Region.

North America is expected to dominate the surgical imaging market, accounting for around one-third of this market. The surgical imaging market is driven by factors such as collaborations among key players, and advanced healthcare facilities in the North American region.

For instance, in November 2022, Hospital for Special Surgery (HSS), the top academic medical center in the world for musculoskeletal health, and medical device and technology company Lazurite collaborated based on Lazurite's ArthroFree Wireless Surgical Camera System, the first wireless surgical camera system to be cleared for market by the U.S. Food and Drug Administration for arthroscopy and general endoscopy.

Competitive Landscape

The major global players in the market include: GE Healthcare, Medtronic Plc., Siemens Healthineers AG, Thales Group, Shimadzu Corporation, Hitachi Ltd, Koninklijke Philips N.V., Ziehm Imaging GmbH, OrthoScan Inc., and Genoray Co. Ltd. among others.

Why Purchase the Report?

  • To visualize the global surgical imaging market segmentation based on the product, technology, application, modality, end-users, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the surgical imaging market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global surgical imaging market report would provide approximately 77 tables, 82 figures, and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Modality
  • 3.4. Snippet by Application
  • 3.5. Snippet by End-users
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in the prevalence of chronic diseases is driving the global surgical imaging market growth.
    • 4.1.2. Restraints
      • 4.1.2.1. High equipment cost is hampering the growth of the global surgical imaging market.
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Analysis

9. By Product

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.1.2. Market Attractiveness Index, By Product
  • 9.2. C-Arms*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. O-Arms
  • 9.4. G-Arms
  • 9.5. Imaging Accessories
  • 9.6. Others

10. By Technology

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.1.2. Market Attractiveness Index, By Technology
  • 10.2. Flat Panel Detectors*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Image Intensifier
  • 10.4. Others

11. By Modality

    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.1.2. Market Attractiveness Index, By Modality
  • 11.2. X-Ray*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. MRI
  • 11.4. CT Scanning
  • 11.5. Ultrasound
  • 11.6. Others

12. By Application

    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.1.2. Market Attractiveness Index, By Application
  • 12.2. Neurological Imaging*
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Orthopaedic and Trauma Imaging
  • 12.4. Cardiovascular Imaging
  • 12.5. Gastrointestinal Imaging
  • 12.6. General Surgery Imaging
  • 12.7. Urological Imaging
  • 12.8. Others

13. By End-users

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 13.1.2. Market Attractiveness Index, By End-users
  • 13.2. Hospitals*
    • 13.2.1. Introduction
    • 13.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 13.3. Ambulatory Surgical Clinics
  • 13.4. Specialty Clinics
  • 13.5. Others

14. By Region

  • 14.1. Introduction
    • 14.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 14.1.2. Market Attractiveness Index, By Region
  • 14.2. North America
    • 14.2.1. Introduction
    • 14.2.2. Key Region-Specific Dynamics
    • 14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 14.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.2.8.1. The U.S.
      • 14.2.8.2. Canada
      • 14.2.8.3. Mexico
  • 14.3. Europe
    • 14.3.1. Introduction
    • 14.3.2. Key Region-Specific Dynamics
    • 14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 14.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.3.8.1. Germany
      • 14.3.8.2. The U.K.
      • 14.3.8.3. France
      • 14.3.8.4. Italy
      • 14.3.8.5. Spain
      • 14.3.8.6. Rest of Europe
  • 14.4. South America
    • 14.4.1. Introduction
    • 14.4.2. Key Region-Specific Dynamics
    • 14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 14.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.4.8.1. Brazil
      • 14.4.8.2. Argentina
      • 14.4.8.3. Rest of South America
  • 14.5. Asia-Pacific
    • 14.5.1. Introduction
    • 14.5.2. Key Region-Specific Dynamics
    • 14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 14.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.5.8.1. China
      • 14.5.8.2. India
      • 14.5.8.3. Japan
      • 14.5.8.4. Australia
      • 14.5.8.5. Rest of Asia-Pacific
  • 14.6. Middle East and Africa
    • 14.6.1. Introduction
    • 14.6.2. Key Region-Specific Dynamics
    • 14.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users

15. Competitive Landscape

  • 15.1. Competitive Scenario
  • 15.2. Product Benchmarking
  • 15.3. Company Share Analysis
  • 15.4. Key Developments and Strategies

16. Company Profiles

  • 16.1. GE Healthcare*
    • 16.1.1. Company Overview
    • 16.1.2. Product Portfolio and Description
    • 16.1.3. Financial Overview
    • 16.1.4. Key Developments
  • 16.2. Medtronic Plc.
  • 16.3. Siemens Healthineers AG
  • 16.4. Thales Group
  • 16.5. Shimadzu Corporation
  • 16.6. Hitachi Ltd
  • 16.7. Koninklijke Philips N.V.
  • 16.8. Ziehm Imaging GmbH
  • 16.9. OrthoScan Inc.
  • 16.10. Genoray Co. Ltd.

LIST NOT EXHAUSTIVE

17. Appendix

  • 17.1. About Us and Services
  • 17.2. Contact Us